Amarin Corp Plc (AMRN)

[Jeffkad]

Doc, what about the potential of currently available MS drugs like Gilenya and just-approved Zeposia? Both are S1P1 receptor agonists that supposedly have a marked ability to reduce cytokine storm, which is a major cause of ARDS. No one is talking about this (only il-6 inhibitors), yet it could be an excellent option to try since it is FDA approved with a known safety profile. If I’m in NYC (or Italy, Spain, etc) I’m looking for anything that can help reduce mortality (as well as reduce need for ventilators, ICUs, etc). Can’t we “trial under fire” now?